重組人血管內皮生長因子受體2蛋白-分析方法-資訊-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

重組人血管內皮生長因子受體2蛋白

作者:上海信裕生物科技有限公司 2023-04-25T00:00 (訪問量:4787)

?重組人血管內皮生長因子受體2蛋白

英文名稱 Recombinant human VEGFR2 protein, His (HEK293)
中文名稱 重組人血管內皮生長因子受體2蛋白
別????名 Vascular endothelial growth factor receptor 2; KDR; VEGF Receptor 2; CD309; CD309 antigen; Fetal liver kinase 1; FLK-1; FLK1; Kinase insert domain receptor (a type III receptor tyrosine kinase); Kinase insert domain receptor; KRD1; Ly73; Protein tyrosine kinase receptor FLK1; Protein-tyrosine kinase receptor flk-1; Tyrosine kinase growth factor receptor; VEGFR 2; VEGFR; VEGFR-2; VGFR2_HUMAN; Recombinant human VEGFR2 protein, His (HEK293)??
理論分子量 87kDa
檢測分子量 140-200 kDa
性????狀 Lyophilized or Liquid
濃????度 >0.5 mg/ml
物????種 Human
序????列 20-764/1356
純????度 >95% as determined by SDS-PAGE
純化方法 AC
內毒素 Not analyzed
表達系統 HEK293 cell
活性 Yes
標簽 His
緩?沖?液 PBS (pH=7.4)
保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
注意事項 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009].
?
產品圖片
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
上海信裕生物科技有限公司 商家主頁

地 址: 上海市閔行莘莊工業區春東路508號A1-2F

聯系人: 徐經理

電 話: 021-60526354

傳 真: 021-37680378

Email:shxysw02@163.com

相關咨詢
ADVERTISEMENT